Evaluation of a Carbon Fiber Device for Spinal Surgery
Official title: Carbofix Pedicle Screw System: Randomized Clinical Trial to Evaluate the Clinical and Radiographic Outcomes of the Use of a Carbon Fiber Device Compared to Titanium Devices in Patients Undergoing Spinal Arthrodesis for Degenerative Spinal Diseases
Run by Istituto Ortopedico Rizzoli · NCT06209684 · Data updated 2026-11-12
This study is testing a new carbon fiber device for spinal surgery to see if it works better than traditional titanium screws for patients with degenerative spinal diseases.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 118 (estimated) |
| Sponsor | Istituto Ortopedico Rizzoli Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | April 29, 2022 |
| Main results expected | September 29, 2026 |
| Study ends | April 29, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT06209684 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older suffering from degenerative spinal pathology or spondylolisthesis requiring instrumented stabilization.
✕Probably not a fit
Patients with metabolic bone diseases, neoplastic diseases, or those who are pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the clinical and radiographic outcomes of using a carbon fiber pedicle screw system compared to traditional titanium devices in patients undergoing spinal fusion for degenerative spinal diseases. It aims to assess the effectiveness of the carbon device, which has previously shown promise in cancer patients due to its low interference with radiation and superior imaging capabilities. A total of 118 patients requiring 1 or 2 levels of lumbar or lumbosacral fusion will be included in the evaluation. The study seeks to fill a gap in the literature regarding the use of carbon fiber in lumbar degenerative pathologies.
Why it matters
Potential benefit: If successful, this study could provide a safer and more effective option for spinal stabilization in patients with degenerative spinal diseases.
How similar studies have gone: While previous studies have shown the effectiveness of carbon devices in cancer patients, this approach in degenerative spinal conditions is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients suffering from degenerative spinal pathology or spondylolisthesis who require instrumented stabilization on 1-2 levels; * Age greater than or equal to 18 years; * Ability to understand and sign the informed consent to the study and to follow the required follow-ups. Exclusion Criteria: * Metabolic bone disease. * History of Paget's disease or other osteodystrophies, whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism, Ehlers-Danlos syndrome, osteogenesis imperfecta, achondroplasia. * Neoplastic disease. * History of mental disorder or current psychiatric treatment. * Pregnancy. * Immunodeficiency diseases. * Infectious bone disease (discitis, osteomyelitis) * Treatment with drugs that can interfere with bone metabolism * Inability to understand and sign the informed consent to the study and to follow the required follow-up visits. * Alcohol and/or drug abuse * Obesity * Metal allergy * Participation in other studies on drugs or devices (within 30 days)
Where it's running
-
Istituto Ortopedico Rizzoli
Bologna, Italy Recruiting
Study contacts
- Study coordinator: Alessandro Gasbarrini, MD
- Email: alessandro.gasbarrini@ior.it
- Phone: 0516366
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bone marrow concentrate injection added to lumbar microdiscectomy
This trial tests whether adding a bone marrow aspirate concentrate injection during lumbar microdiscectomy helps adults recover better than surgery alone.
-
IDCT (Intradiscal Cell Therapy) for single-level mild-to-moderate lumbar degenerative disc disease
This will test whether injecting IDCT (rebonuputemcel) into one degenerating lower-back disc can reduce chronic low back pain in adults with mild-to-moderate lumbar degenerative disc disease.
-
Novosis Putty used with transforaminal lumbar interbody fusion for lumbar degenerative disc disease
The trial will test whether using Novosis Putty during transforaminal lumbar interbody fusion helps adults with lumbar degenerative disc disease heal better compared with standard care.
-
Evaluating a new treatment for painful disc degeneration
This study is testing a new non-surgical treatment for people with painful disc degeneration to see if it can help relieve their back pain when other treatments haven't worked.
-
Evaluating a hybrid surgical approach for cervical degenerative disc disease
This study is testing a new combined surgery for people with neck pain from two damaged discs to see if it works better and is safer than traditional surgery.
-
Evaluating LDGraft for lumbar spine surgery
This study is testing a new device called LDGraft to see if it is safe and effective for patients having surgery for lower back problems compared to using human tissue.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.